MA
AXSM icon

MONECO Advisors’s Axsome Therapeutics AXSM Stock Holding History

MONECO Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Sell
7,472
-33
-0.4% -$5.7K 0.1% 183
2025
Q4 		$1.37M Hold
7,505
– – 0.11% 171
2025
Q3 		$911K Hold
7,505
– – 0.08% 216
2025
Q2 		$783K Hold
7,505
– – 0.07% 221
2025
Q1 		$875K Sell
7,505
-8
-0.1% -$911 0.09% 193
2024
Q4 		$636K Buy
7,513
+48
+0.6% +$4.41K 0.07% 239
2024
Q3 		$671K Sell
7,465
-20
-0.3% -$1.75K 0.08% 205
2024
Q2 		$603K Hold
7,485
– – 0.09% 209
2024
Q1 		$597K Hold
7,485
– – 0.09% 219
2023
Q4 		$596K Hold
7,485
– – 0.11% 197
2023
Q3 		$523K Hold
7,485
– – 0.14% 167
2023
Q2 		$538K Sell
7,485
-615
-8% -$45.4K 0.15% 164
2023
Q1 		$500K Buy
8,100
+100
+1% +$6.57K 0.15% 160
2022
Q4 		$617K Sell
8,000
-100
-1% -$5.98K 0.22% 112
2022
Q3 		$361K Sell
8,100
-830
-9% -$41.5K 0.14% 156
2022
Q2 		$342K Hold
8,930
– – 0.13% 162
2022
Q1 		$370K Hold
8,930
– – 0.14% 151
2021
Q4 		$241K Buy
8,930
+500
+6% +$18.4K 0.09% 209
2021
Q3 		$278K Buy
+8,430
New +$329K 0.11% 192

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MONECO Advisors's AXSM Position: Q1 2026 in Review

MONECO Advisors reduced its Axsome Therapeutics (AXSM) stake by 0.44% in Q1 2026, selling an estimated $5.7K and leaving 7,472 shares worth $1.26M. The position accounts for 0.1% of the portfolio, ranked #183.

MONECO Advisors first reported a position in AXSM in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.37M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • MONECO Advisors held 7,472 shares of Axsome Therapeutics worth $1.26M as of Q1 2026.
  • MONECO Advisors sold 33 Axsome Therapeutics shares in Q1 2026, an estimated $5.7K.
  • Axsome Therapeutics made up 0.1% of MONECO Advisors's portfolio in Q1 2026, its #183 holding.
  • MONECO Advisors first reported a position in Axsome Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • MONECO Advisors's Axsome Therapeutics position peaked at $1.37M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.